Gerd Geerling
Prof Gerd Geerling is an expert in Ophthalmology at Düsseldorf University Hospital (Germany). As of October 2026, ScienceLeadR ranks Gerd Geerling in the top 1% of experts worldwide for Corneal Diseases. Gerd Geerling has authored 522 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 2 of them ongoing. SLR score: 1,579 (community average: 125). How the SLR is computed.
LeadR Profile
Ophthalmology
Subspecialties: Endocrinology - Surgery - Otolaryngology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1992 - 2026
Number : 522
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Cyclosporin (0.09%) Ophthalmic Solution for the Treatment of Dry Eye Disease - A Narrative Review. PMID 42473077 — cells, tumor necrosis factor-alpha, ophthalmology, keratoconjunctivitis sicca, solutions, signs and symptoms, cyclosporine, interleukin-1, ophthalmic solutions, eye diseases, therapeutics, dry eye syndromes | Curr Eye Res | 2026 | 0 |
| The German National Cohort: Ophthalmic Assessment, Baseline Profile, and Potential for Artificial Intelligence-Based Eye Research. PMID 42894708 — research design, intelligence, blood, blood pressure, deep learning, visual acuity, sex, research, learning, artificial intelligence | Ophthalmol Sci | 2026 | 0 |
| Success of femtosecond laser-assisted deep anterior lamellar keratoplasty (Femto-DALK): a clinical case series of 42 eyes using an intraoperative optical coherence tomography (iOCT)-guided laser-generated pre-descemet tunnel. PMID 42875753 — eye, corneal transplantation, tomography, lasers, tomography, optical coherence, eye diseases, membranes | BMC Ophthalmol | 2026 | 0 |
| [Ethical, legal and care-related aspects of the competence to refrain from diagnostics and treatment : Choosing wisely]. PMID 42853391 — ophthalmology, physicians, eye diseases, therapeutics | Ophthalmologie | 2026 | 0 |
| Sex-Specific Differences in Corneal Remodeling after Descemet Membrane Endothelial Keratoplasty in Fuchs Endothelial Corneal Dystrophy. PMID 42830895 — eye, cells, fuchs' endothelial dystrophy, corneal transplantation, corneal dystrophies, hereditary, visual acuity, descemet membrane, sex, membranes | Ophthalmol Sci | 2026 | 0 |
Clinical Studies 10
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| An efficacy and safety study of cenegermin ophthalmic solution compared with vehicle in the treatment of PCED 2025-523443-35-00 — eye, growth, safety, solutions, nerve growth factor, ophthalmic solutions, therapeutics, pharmaceutical vehicles | Phase 3 | Recruiting | 2026 |
| Pretreatment to Promote Graft Survival After Subsequent High risk Corneal Transplantation CrossCornealVision NCT05870566 — cells, safety, microscopy, electron, scanning transmission, corneal transplantation, vitamins, ultraviolet rays, cornea, stem cells, graft survival, lymph, flavin mononucleotide, transplants, therapeutics, debridement, riboflavin, transplantation | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map